Contact this trialFirst, we need to learn more about you.
ARD-101 +1 More for Obesity
Recruiting0 awardsPhase 2
San Diego, California
This trial will study the safety and effectiveness of a new drug, ARD-101, for treating obesity in adults. The trial will last for 12 weeks and will enroll obese adults with a BMI of 30-45 kg/m2.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.